Pharmaceutical companies are facing a potential hit as President Trump considers imposing tariffs on pharmaceutical imports, causing stock prices to fall. Companies like Johnson & Johnson, Eli Lilly, and Merck are already investing billions in expanding their manufacturing in the US in anticipation of the tariffs. European-based companies like AstraZeneca and GSK are also monitoring the situation closely, as trade groups warn of a potential shift to the US market if the EU does not strengthen its regulations.
Full Article
Luigi Mangione’s attorneys accuse prosecutors of illegally obtaining his medical records
Attorneys for Luigi Mangione, accused of murdering United HealthCare CEO Brian Thompson, allege that Manhattan prosecutors violated HIPAA by improperly obtaining his medical records through a fraudulent subpoena. They seek a hearing to impose sanctions, potentially including dismissal of charges, while the Manhattan DA's office claims the information was inadvertently sent by Aetna and promptly deleted upon discovery. Explain It To Me Like I'm 5: Luigi Mangione's lawyers are saying that the people trying to...
Read more